These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9033261)

  • 1. Immunohistochemical study suggesting a complementary role of kallikreins hK2 and hK3 (prostate-specific antigen) in the functional analysis of human prostate tumors.
    Tremblay RR; Deperthes D; Têtu B; Dubé JY
    Am J Pathol; 1997 Feb; 150(2):455-9. PubMed ID: 9033261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
    Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
    Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human glandular kallikrein, hK2, in mammalian cells.
    Kumar A; Goel AS; Hill TM; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Saedi MS
    Cancer Res; 1996 Dec; 56(23):5397-402. PubMed ID: 8968092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free and total human glandular kallikrein 2 in patients with prostate cancer.
    Väisänen V; Pettersson K; Alanen K; Viitanen T; Nurmi M
    Urology; 2006 Jul; 68(1):219-25. PubMed ID: 16844459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer.
    Stephan C; Jung K; Nakamura T; Yousef GM; Kristiansen G; Diamandis EP
    Int J Urol; 2006 Mar; 13(3):238-43. PubMed ID: 16643616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
    Charlesworth MC; Young CY; Miller VM; Tindall DJ
    J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.
    Fisher TL; Nocera M; Willis RA; Turner MJ; Abdul Alim CS; Brown DM; Bourne PA; di Sant'Agnese PA; Messing EM; Lord EM; Frelinger JG
    Prostate; 2002 May; 51(3):153-65. PubMed ID: 11967950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
    Steuber T; Niemela P; Haese A; Pettersson K; Erbersdobler A; Felix Chun KH; Graefen M; Kattan MW; Huland H; Lilja H
    Prostate; 2005 Apr; 63(1):13-8. PubMed ID: 15378521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
    Mize GJ; Wang W; Takayama TK
    Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific human kallikrein (hK2) as a novel marker for prostate cancer.
    Young CY; Seay T; Hogen K; Charlesworth MC; Roche PC; Klee GG; Tindall DJ
    Prostate Suppl; 1996; 7():17-24. PubMed ID: 8950360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.
    Haese A; Vaisanen V; Lilja H; Kattan MW; Rittenhouse HG; Pettersson K; Chan DW; Huland H; Sokoll LJ; Partin AW
    J Urol; 2005 Mar; 173(3):752-6. PubMed ID: 15711262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D.
    Hsieh ML; Charlesworth MC; Goodmanson M; Zhang S; Seay T; Klee GG; Tindall DJ; Young CY
    Cancer Res; 1997 Jul; 57(13):2651-6. PubMed ID: 9205072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative concentrations of hK2/PSA mRNA in benign and malignant prostatic tissue.
    Lintula S; Stenman J; Bjartell A; Nordling S; Stenman UH
    Prostate; 2005 Jun; 63(4):324-9. PubMed ID: 15599939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer.
    Pannek J; Rittenhouse HG; Evans CL; Finlay JA; Bruzek DJ; Cox JL; Chan DW; Subong EN; Partin AW
    Urology; 1997 Nov; 50(5):715-21. PubMed ID: 9372881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.
    Shariat SF; Roudier MP; Wilcox GE; Kattan MW; Scardino PT; Vessella RL; Erdamar S; Nguyen C; Wheeler TM; Slawin KM
    Cancer Res; 2003 Aug; 63(15):4662-70. PubMed ID: 12907647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids.
    Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A
    J Androl; 1999; 20(3):348-55. PubMed ID: 10386814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum human glandular kallikrein (hK2) and insulin-like growth factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA.
    Scorilas A; Plebani M; Mazza S; Basso D; Soosaipillai AR; Katsaros N; Pagano F; Diamandis EP
    Prostate; 2003 Feb; 54(3):220-9. PubMed ID: 12518327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein.
    Slawin KM; Shariat SF; Nguyen C; Leventis AK; Song W; Kattan MW; Young CY; Tindall DJ; Wheeler TM
    Cancer Res; 2000 Dec; 60(24):7142-8. PubMed ID: 11156423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues.
    Björk T; Schalken J; Wittjes W; Ljungberg B; Lilja H
    Prostate; 2001 Apr; 47(1):14-20. PubMed ID: 11304725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
    Becker C; Piironen T; Pettersson K; Björk T; Wojno KJ; Oesterling JE; Lilja H
    J Urol; 2000 Jan; 163(1):311-6. PubMed ID: 10604382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.